Effects of pramlintide, an amylin analogue, on gastric emptying in type 1 and 2 diabetes mellitus

Predicting basal metabolic rate, new standards and review of previous work.

Wn, S. (1985) · PubMed · Cited by 2,911 · see citing works

A Patient Questionnaire to Identify Bowel Disease

Talley, N. J., Phillips, S. F., Melton, L. J., Wiltgen, C., & Zinsmeister, A. R. (1989) · Annals of Internal Medicine · doi:10.7326/0003-4819-111-8-671 · Cited by 444 · see citing works

Effect of Proximal Gastric, Complete Gastric, and Truncal Vagotomy on Canine Gastric Electric Activity, Motility, and Emptying

Wilbur, B. G., & Kelly, K. A. (1973) · Annals of Surgery · doi:10.1097/00000658-197309000-00009 · Cited by 285 · see citing works

In vitro autoradiographic localization of amylin binding sites in rat brain

Sexton, P. M., Paxinos, G., Kenney, M. A., Wookey, P. J., & Beaumont, K. C. (1994) · Neuroscience · doi:10.1016/0306-4522(94)90388-3 · Cited by 277 · see citing works

beta-cell apoptosis: stimuli and signaling.

Mandrup-Poulsen, T. R. (2001) · Diabetes · doi:10.2337/diabetes.50.2007.s58 · Cited by 253 · see citing works

Islet Amyloid Polypeptide in Patients with Pancreatic Cancer and Diabetes

Permert, J., Larsson, J., Westermark, G. T., Herrington, M. K., Christmanson, L., Pour, P. M., Westermark, P., & Adrian, T. E. (1994) · New England Journal of Medicine · doi:10.1056/nejm199402033300503 · Cited by 237 · see citing works

Natural history of diabetic gastroparesis.

Kong, M., Horowitz, M., Jones, K. L., Wishart, J. M., & Harding, P. E. (1999) · Diabetes Care · doi:10.2337/diacare.22.3.503 · Cited by 228 · see citing works

High affinity amylin binding sites in rat brain.

Beaumont, K. C., Kenney, M. A., Young, A. A., & RINK, T. J. (1993) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13212-4 · Cited by 208 · see citing works

Gastric emptying is accelerated in diabetic BB rats and is slowed by subcutaneous injections of amylin

Young, A. A., Gedulin, B. R., Vine, W., Percy, A., & RINK, T. J. (1995) · Diabetologia · doi:10.1007/bf00401833 · Cited by 184 · see citing works

Dose-response for glucagonostatic effect of amylin in rats

Gedulin, B. R., RINK, T. J., & Young, A. A. (1997) · Metabolism · doi:10.1016/s0026-0495(97)90170-0 · Cited by 180 · see citing works

The molecular pharmacology of CGRP and related peptide receptor subtypes

Juanéda, C., Dumont, Y., & Quirion, R. (2000) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01555-8 · Cited by 173 · see citing works

Clinical diagnosis with the stable isotope 13C in CO2 breath tests: methodology and fundamental considerations.

Schoeller, D. A., Schneider, J. F., Solomons, N. W., Watkins, J. B., & Klein, P. (1977) · PubMed · Cited by 171 · see citing works

Preliminary report Dose-responses for the slowing of gastric emptying in a rodent model by glucagon-like peptide (7–36)NH2, amylin, cholecystokinin, and other possible regulators of nutrient uptake

Young, A. A., Gedulin, B. R., & RINK, T. J. (1996) · Metabolism · doi:10.1016/s0026-0495(96)90192-4 · Cited by 150 · see citing works

Pramlintide, an amylin analog, selectively delays gastric emptying: potential role of vagal inhibition

Samsom, M., Szarka, L. A., Camilleri, M., Vella, A. V., Zinsmeister, A. R., & Rizza, R. A. (2000) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.2000.278.6.g946 · Cited by 147 · see citing works

Amylin concentrations and glucose control

Koda, J., Fineman, M. S., RINK, T. J., Dailey, G., Muchmore, D. B., & Linarelli, L. G. (1992) · The Lancet · doi:10.1016/0140-6736(92)90785-2 · Cited by 145 · see citing works

Neurohormonal Factors in Functional Dyspepsia: Insights on Pathophysiological Mechanisms

Greydanus, M. P., Vassallo, M., Camilleri, M., Nelson, D. K., Hanson, R. B., & Thomforde, G. M. (1991) · Gastroenterology · doi:10.1016/0016-5085(91)70018-s · Cited by 138 · see citing works

Infusion of pramlintide, a human amylin analogue, delays gastric emptying in men with IDDM

Kong, M.-F., King, P., Macdonald, I. A., Stubbs, T. A., Perkins, A. C., Blackshaw, P. E., Moyses, C., & Tattersall, R. B. (1997) · Diabetologia · doi:10.1007/s001250050646 · Cited by 131 · see citing works

Islet amyloid polypeptide (IAPP): cDNA cloning and identification of an amyloidogenic region associated with the species-specific occurrence of age-related diabetes mellitus

Betsholtz, C., Svensson, V., Rorsman, F., Engström, U., Westermark, G. T., Wilander, E., Johnson, K. H., & Westermark, P. (1989) · Experimental Cell Research · doi:10.1016/0014-4827(89)90407-2 · Cited by 125 · see citing works

Abnormalities in G protein-coupled signal transduction pathways in human disease.

Am, S., Weinstein, L. S., & Shenker, A. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116680 · Cited by 117 · see citing works

Practical Closed-Loop Insulin Delivery

White, N. H., SKOR, D., & SANTIAGO, J. V. (1982) · Annals of Internal Medicine · doi:10.7326/0003-4819-97-2-210 · Cited by 109 · see citing works

The effect of single doses of pramlintide on gastric emptying of two meals in men with IDDM

Kong, M.-F., Stubbs, T. A., King, P., Macdonald, I. A., Lambourne, J. E., Blackshaw, P. E., Perkins, A. C., & Tattersall, R. B. (1998) · Diabetologia · doi:10.1007/s001250050949 · Cited by 106 · see citing works

Structure and biology of amylin

RINK, T. J., Beaumont, K. C., Koda, J. E., & Young, A. W. (1993) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(93)90081-t · Cited by 105 · see citing works

A valid, accurate, office based non-radioactive test for gastric emptying of solids

Lee, J. S., Camilleri, M., ZINSMEISTER, A. R., Burton, D. D., Kost, L. J., & Klein, P. (2000) · Gut · doi:10.1136/gut.46.6.768 · Cited by 100 · see citing works

Activation of the Parasympathetic Nervous System Is Necessary for Normal Meal-Induced Insulin Secretion in Rhesus Macaques1

D’Alessio, D. A., Kieffer, T. J., Taborsky, G. J., & Havel, P. J. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.3.7367 · Cited by 96 · see citing works

Pramlintide, a Synthetic Analog of Human Amylin, Improves the Metabolic Profile of Patients With Type 2 Diabetes Using Insulin

Thompson, R. G., Pearson, L. L., Schoenfeld, S., Kolterman, O., & The Pramlintide in Type 2 Diabetes Group (1998) · Diabetes Care · doi:10.2337/diacare.21.6.987 · Cited by 87 · see citing works

Normalizing Results of 13C-Urea Breath Testing for CO2 Production Rates in Children

Klein, P., Malaty, H. M., Czinn, S. J., Emmons, S. J., Martin, R. F., & Graham, D. Y. (1999) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/00005176-199909000-00011 · Cited by 87 · see citing works

Reduction of Postprandial Hyperglycemia in Subjects With IDDM by Intravenous Infusion of AC137, a Human Amylin Analogue

Kolterman, O., Gottlieb, A., Moyses, C., & Colburn, W. A. (1995) · Diabetes Care · doi:10.2337/diacare.18.8.1179 · Cited by 79 · see citing works

The Classification of Diabetes by Clinical and C-Peptide Criteria: A prospective population-based study

Service, F. J., Rizza, R. A., Zimmerman, B. R., Dyck, P. J. B., O’Brien, P. C., & Melton, L. J. (1997) · Diabetes Care · doi:10.2337/diacare.20.2.198 · Cited by 73 · see citing works

Mechanisms of the antidiabetic action of subcutaneous glucagon-like peptide-1(7-36)amide in non-insulin dependent diabetes mellitus

Schirra, J. R. J., Leicht, P., Hildebrand, P., Beglinger, C., Arnold, R., Göke, B., & Katschinski, M. (1998) · Journal of Endocrinology · doi:10.1677/joe.0.1560177 · Cited by 65 · see citing works

Hypoglycemia Overrides Amylin-Mediated Regulation of Gastric Emptying in Rats

Gedulin, B. R., & Young, A. A. (1998) · Diabetes · doi:10.2337/diab.47.1.93 · Cited by 64 · see citing works

Activation of the Parasympathetic Nervous System Is Necessary for Normal Meal-Induced Insulin Secretion in Rhesus Macaques

D’Alessio, D. A. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.3.1253 · Cited by 56 · see citing works

Amylin regulation of carbohydrate metabolism

Young, A., Pittner, R. A., Gedulin, B. R., Vine, W., & RINK, T. J. (1995) · Biochemical Society Transactions · doi:10.1042/bst0230325 · Cited by 49 · see citing works

Effects of 4 weeks’ administration of pramlintide, a human amylin analogue, on glycaemia control in patients with IDDM: effects on plasma glucose profiles and serum fructosamine concentrations

Thompson, R., Pearson, L., & Kolterman, O. (1997) · Diabetologia · doi:10.1007/s001250050821 · Cited by 46 · see citing works

Can Plasma Human Pancreatic Polypeptide Be Used To Detect Diseases of the Exocrine Pancreas?

KOCH, M. B., Go, V. L. W., & DiMagno, E. P. (1985) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(12)60319-x · Cited by 45 · see citing works

Autonomic dysfunction in patients with chronic intestinal pseudo-obstruction

Camilleri, M., Balm, R. K., & Low, P. A. (1993) · Clinical Autonomic Research · doi:10.1007/bf01818993 · Cited by 44 · see citing works

Clinical applications of 13CO2 measurements.

Pd, K. (1982) · PubMed · Cited by 39 · see citing works

Deficiency of Total and Nonglycosylated Amylin in Plasma Characterizes Subjects with Impaired Glucose Tolerance and Type 2 Diabetes

Mäkimattila, S., Fineman, M. S., & Yki‐Järvinen, H. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.8.6721 · Cited by 34 · see citing works

Neural regulation of pancreatic polypeptide release.

Prinz, R. A., Sabbagh, H. E., Adrian, T. E., Bloom, S. R., Gardner, I., Polak, J. M., INOKUCHI, H., Bishop, A. E., & Welbourn, R. B. (1983) · PubMed · Cited by 28 · see citing works

Influence of glucose concentration on the inhibitory effect of amylin on insulin secretion. Study in the perfused rat pancreas

Silvestre, R. A., Rodríguez‐Gallardo, J., Gutiérrez, E., & Marco, J. (1997) · Regulatory Peptides · doi:10.1016/s0167-0115(96)00139-5 · Cited by 16 · see citing works

Time-dependent effects of vagotomy on pancreatic polypeptide release

Taylor, I. L., Singer, M. V., & Kauffman, G. L. (1982) · Digestive Diseases and Sciences · doi:10.1007/bf01296726 · Cited by 10 · see citing works

Clinical Guideline: Management of Gastroparesis

Camilleri, M., Parkman, H. P., Shafi, M. A., Abell, T. L., & Gerson, L. (2013) · American Journal of Gastroenterology · doi:10.1038/ajg.2012.373 · Cited by 1,149 · see citing works

Evaluation of gastrointestinal transit in clinical practice: position paper of the American and European Neurogastroenterology and Motility Societies

Rao, S. S. C., Camilleri, M., Hasler, W. L., Maurer, A. H., Parkman, H. P., Saad, R., Scott, S. M., Simrén, M., Soffer, E., & Szarka, L. A. (2010) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2010.01612.x · Cited by 383 · see citing works

Review article: the role of gastric motility in the control of food intake

Janssen, P., Berghe, P. V., Verschueren, S., Lehmann, A., Depoortere, I., & Tack, J. F. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04609.x · Cited by 347 · see citing works

Diabetic Gastroparesis

Camilleri, M. (2007) · New England Journal of Medicine · doi:10.1056/nejmcp062614 · Cited by 329 · see citing works

Pramlintide as an Adjunct to Insulin Therapy Improves Long-Term Glycemic and Weight Control in Patients With Type 2 Diabetes

Hollander, P. A., Levy, P., Fineman, M. S., Maggs, D. G., Shen, L. Z., Strobel, S. A., Weyer, C., & Kolterman, O. G. (2003) · Diabetes Care · doi:10.2337/diacare.26.3.784 · Cited by 307 · see citing works

Integrated Upper Gastrointestinal Response to Food Intake

Camilleri, M. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.03.023 · Cited by 247 · see citing works

Gastrointestinal motility disorders in neurologic disease

Camilleri, M. (2021) · Journal of Clinical Investigation · doi:10.1172/jci143771 · Cited by 211 · see citing works

Effect of pramlintide on satiety and food intake in obese subjects and subjects with type 2 diabetes

Chapman, I., Parker, B., Doran, S., Feinle-Bisset, C., Wishart, J., Strobel, S., Wang, Y., Burns, C., Lush, C., Weyer, C., et al. (2005) · Diabetologia · doi:10.1007/s00125-005-1732-4 · Cited by 205 · see citing works

Effect of Pramlintide on Weight in Overweight and Obese Insulin‐Treated Type 2 Diabetes Patients

Hollander, P. A., Maggs, D. G., Ruggles, J. A., Fineman, M. S., Shen, L. Z., Kolterman, O., & Weyer, C. (2004) · Obesity Research · doi:10.1038/oby.2004.76 · Cited by 191 · see citing works

Diabetic gastroparesis: what we have learned and had to unlearn in the past 5 years: Figure 1

Kashyap, P., & Farrugia, G. (2010) · Gut · doi:10.1136/gut.2009.199703 · Cited by 175 · see citing works

Pramlintide in the treatment of type 1 and type 2 diabetes mellitus

Ryan, G. J., Jobe, L. J., & Martin, R. (2005) · Clinical Therapeutics · doi:10.1016/j.clinthera.2005.10.009 · Cited by 159 · see citing works

Effect of Pramlintide on Prandial Glycemic Excursions During Closed-Loop Control in Adolescents and Young Adults With Type 1 Diabetes

WEINZIMER, S. A., Sherr, J. L., Cengiz, E., Kim, G. E., Ruiz, J., CARRIA, L. R., Voskanyan, G. R., Roy, A., & Tamborlane, W. V. (2012) · Diabetes Care · doi:10.2337/dc12-0330 · Cited by 134 · see citing works

Gastrointestinal hormones and regulation of gastric emptying

Camilleri, M. (2018) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000448 · Cited by 130 · see citing works

Gastroparesis: Clinical Update. CME

Park, M. I., & Camilleri, M. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00640.x · Cited by 129 · see citing works

Chronic nausea and vomiting: evaluation and treatment

Lacy, B. E., Parkman, H. P., & Camilleri, M. (2018) · The American Journal of Gastroenterology · doi:10.1038/s41395-018-0039-2 · Cited by 127 · see citing works

Prevention and treatment of type 2 diabetes: Current role of lifestyle, natural product, and pharmacological interventions

Hays, N. P., Galassetti, P. R., & Coker, R. H. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.02.003 · Cited by 122 · see citing works

Metoclopramide in the treatment of diabetic gastroparesis

Lee, A. A., & Kuo, B. (2010) · Expert Review of Endocrinology & Metabolism · doi:10.1586/eem.10.41 · Cited by 116 · see citing works

Emerging Therapies Mimicking the Effects of Amylin and Glucagon-Like Peptide 1

Riddle, M. C., & Drucker, D. J. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1267 · Cited by 108 · see citing works

Pramlintide Reduces Postprandial Glucose Excursions When Added to Regular Insulin or Insulin Lispro in Subjects With Type 1 Diabetes

Weyer, C., Gottlieb, A., Kim, D. D. H., Lutz, K., Schwartz, S. L., Gutiérrez, M. E. H., Wang, Y., Ruggles, J. A., Kolterman, O., & Maggs, D. G. (2003) · Diabetes Care · doi:10.2337/diacare.26.11.3074 · Cited by 107 · see citing works

Pharmacological actions of the peptide hormone amylin in the long-term regulation of food intake, food preference, and body weight.

Mack, C. M., Wilson, J., Athanacio, J., Reynolds, J. M., Laugero, K., Guss, S., Vu, C., Roth, J., & Parkes, D. (2007) · American Journal of Physiology. Regulatory Integrative and Comparative Physiology · doi:10.1152/ajpregu.00297.2007 · Cited by 115 · see citing works

Relationship between glycemic control and gastric emptying in poorly controlled type 2 diabetes

Bharucha, A. E., Kudva, Y., Basu, A., Camilleri, M., Low, P. A., Vella, A., & Zinsmeister, A. R. (2015) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.06.034 · Cited by 105 · see citing works

Pramlintide and the treatment of diabetes: a review of the data since its introduction

Younk, L. M., Mikeladze, M., & Davis, S. N. (2011) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2011.581663 · Cited by 99 · see citing works

The Role of Amylin and Glucagon in the Dampening of Glycemic Excursions in Children With Type 1 Diabetes

Heptulla, R. A., Rodríguez, L. M., Bomgaars, L. R., & Haymond, M. W. (2005) · Diabetes · doi:10.2337/diabetes.54.4.1100 · Cited by 88 · see citing works

Role and Cytotoxicity of Amylin and Protection of Pancreatic Islet β-Cells from Amylin Cytotoxicity

Kiriyama, Y., & Nochi, H. (2018) · Cells · doi:10.3390/cells7080095 · Cited by 86 · see citing works

Pramlintide, the synthetic analogue of amylin: physiology, pathophysiology, and effects on glycemic control, body weight, and selected biomarkers of vascular risk

Hoogwerf, B. J. (2008) · Vascular Health and Risk Management · doi:10.2147/vhrm.s1978 · Cited by 87 · see citing works

Role of Amylin in Type 1 and Type 2 Diabetes

Hieronymus, L. B., & Griffin, S. (2015) · The Science of Diabetes Self-Management and Care · doi:10.1177/0145721715607642 · Cited by 86 · see citing works

Relationship Between Control of Glycemia and Gastric Emptying Disturbances in Diabetes Mellitus

Halland, M., & Bharucha, A. E. (2015) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2015.11.021 · Cited by 84 · see citing works

Role of endogenous amylin in glucagon secretion and gastric emptying in rats demonstrated with the selective antagonist, AC187

Gedulin, B. R., Jodka, C. M., Herrmann, K., & Young, A. A. (2006) · Regulatory Peptides · doi:10.1016/j.regpep.2006.06.004 · Cited by 81 · see citing works

Islet amyloid polypeptide: Another key molecule in Alzheimer’s pathogenesis?

Zhang, Y., & Song, W. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2017.03.001 · Cited by 78 · see citing works

Pramlintide reduces postprandial glucose excursions when added to insulin lispro in subjects with type 2 diabetes: a dose‐timing study

Maggs, D. G., Fineman, M. S., Kornstein, J., Burrell, T., Schwartz, S. L., Wang, Y., Ruggles, J. A., Kolterman, O., & Weyer, C. (2004) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.419 · Cited by 77 · see citing works

Inhibition of Gastric Emptying

Young, A. (2005) · Advances in pharmacology · doi:10.1016/s1054-3589(05)52006-4 · Cited by 75 · see citing works

Effects of Pramlintide on Postprandial Glucose Excursions and Measures of Oxidative Stress in Patients With Type 1 Diabetes

Ceriello, A., Piconi, L., Quagliaro, L., Wang, Y., Schnabel, C. A., Ruggles, J. A., Gloster, M., Maggs, D. G., & Weyer, C. (2005) · Diabetes Care · doi:10.2337/diacare.28.3.632 · Cited by 75 · see citing works

Pramlintide in the Treatment of Diabetes Mellitus

Edelman, S. V., Maier, H., & Wilhelm, K. (2008) · BioDrugs · doi:10.2165/0063030-200822060-00004 · Cited by 68 · see citing works

Randomized comparison of pramlintide or mealtime insulin added to basal insulin treatment for patients with type 2 diabetes

Riddle, M., Pencek, R., Charenkavanich, S., Lutz, K., Wilhelm, K., & Porter, L. (2009) · Diabetes Care · doi:10.2337/dc09-0395 · Cited by 66 · see citing works

Amylin-mediated control of glycemia, energy balance, and cognition

Mietlicki‐Baase, E. G. (2016) · Physiology & Behavior · doi:10.1016/j.physbeh.2016.02.034 · Cited by 62 · see citing works

Mango modulates body fat and plasma glucose and lipids in mice fed a high-fat diet

Lucas, E. A., Li, W., Peterson, S., Brown, A., Kuvibidila, S. R., Perkins-Veazie, P. M., Clarke, S. L., & Smith, B. J. (2011) · British Journal Of Nutrition · doi:10.1017/s0007114511002066 · Cited by 57 · see citing works

IAPP and type 1 diabetes: implications for immunity, metabolism and islet transplants

Denroche, H. C., & Verchere, C. B. (2018) · Journal of Molecular Endocrinology · doi:10.1530/jme-17-0138 · Cited by 51 · see citing works

Glucoregulatory effects and prolonged duration of action of davalintide: a novel amylinomimetic peptide

Mack, C. M., Smith, P. A., Athanacio, J., Xu, K., Wilson, J., Reynolds, J. M., Jodka, C. M., Lu, M. G. W., & Parkes, D. G. (2011) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01465.x · Cited by 50 · see citing works

Diabetes mellitus and gastric emptying: questions and issues in clinical practice

Samsom, M., Bharucha, A. E., Gerich, J. E., Herrmann, K., Limmer, J., Linke, R., Maggs, D. G., Schirra, J. R. J., Vella, A. V., Wörle, H., et al. (2009) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.974 · Cited by 47 · see citing works

Novel Pharmacologic Agents for Type 2 Diabetes

Uwaifo, G. I., & Ratner, R. E. (2005) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2004.11.006 · Cited by 45 · see citing works

Pathophysiology, Aetiology and Treatment of Gastroparesis

Sullivan, A., Temperley, L., & Ruban, A. (2020) · Digestive Diseases and Sciences · doi:10.1007/s10620-020-06287-2 · Cited by 43 · see citing works

Living with the enemy: from protein-misfolding pathologies we know, to those we want to know

Emwas, A.-H. M., Alghrably, M., Dhahri, M., Sharfalddin, A. A., Alsiary, R., Jaremko, M., Faa, G., Campagna, M., Congiu, T., Piras, M., et al. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101391 · Cited by 43 · see citing works

Diabetic gastroparesis and its impact on glycemia.

Chang, J., Rayner, C., Jones, K., & Horowitz, M. (2010) · Endocrinology and metabolism clinics of North America (Print) · doi:10.1016/j.ecl.2010.08.007 · Cited by 41 · see citing works

Diabetic gastroparesis—Backwards and forwards

Chang, J., Rayner, C. K., Jones, K. L., & Horowitz, M. (2011) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2010.06573.x · Cited by 40 · see citing works

Weight Considerations in Pharmacotherapy for Type 2 Diabetes

Cheng, V., & Kashyap, S. R. (2010) · Journal of Obesity · doi:10.1155/2011/984245 · Cited by 39 · see citing works

Pramlintide Lowered Glucose Excursions and Was Well-Tolerated in Adolescents with Type 1 Diabetes: Results from a Randomized, Single-Blind, Placebo-Controlled, Crossover Study

Chase, H. P., Lutz, K., Pencek, R., Zhang, B., & Porter, L. (2009) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2009.03.012 · Cited by 39 · see citing works

Does receptor balance matter? – Comparing the efficacies of the dual amylin and calcitonin receptor agonists cagrilintide and KBP-336 on metabolic parameters in preclinical models

Larsen, A. T., Mohamed, K. E., Sonne, N., BREDTOFT, E.-M., Andersen, F., Karsdal, M. A., & Henriksen, K. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113842 · Cited by 38 · see citing works

Pramlintide as An Adjunct to Insulin in Patients with Type 2 Diabetes in A Clinical Practice Setting Reduced A1C, Postprandial Glucose Excursions, And Weight

Karl, D. M., Philis‐Tsimikas, A., Darsow, T., Lorenzi, G. M., Kellmeyer, T., Lutz, K., Wang, Y., & Frías, J. P. (2007) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2006.0013 · Cited by 38 · see citing works

Pramlintide for the Treatment of Diabetes Mellitus

Kleppinger, E. L., & Vivian, E. (2003) · Annals of Pharmacotherapy · doi:10.1345/aph.1c387 · Cited by 37 · see citing works

Effects of delayed gastric emptying on postprandial glucose kinetics, insulin sensitivity, and β-cell function

Hinshaw, L., Schiavon, M., Mallad, A., Man, C. D., Basu, R., Bharucha, A. E., Cobelli, C., Carter, R. E., Basu, A., & Kudva, Y. C. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00199.2014 · Cited by 35 · see citing works

What are the important subsets of gastroparesis?

Camilleri, M., Grover, M., & Farrugia, G. (2012) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2012.01942.x · Cited by 32 · see citing works

Effect of pramlintide as an adjunct to basal insulin on markers of cardiovascular risk in patients with type 2 diabetes

Wysham, C., Lush, C. W., Zhang, B., Maier, H., & Wilhelm, K. (2007) · Current Medical Research and Opinion · doi:10.1185/030079908x253537 · Cited by 32 · see citing works

Xenin-25 delays gastric emptying and reduces postprandial glucose levels in humans with and without Type 2 diabetes

Chowdhury, S., Reeds, D. N., Crimmins, D. L., Patterson, B. W., Laciny, E., Wang, S., Tran, H. D., Griest, T. A., Rometo, D. A., Dunai, J., et al. (2013) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00383.2013 · Cited by 29 · see citing works

The science of safety: adverse effects of GLP-1 receptor agonists as glucose-lowering and obesity medications

Jalleh, R. J., Talley, N. J., Horowitz, M., & Nauck, M. A. (2026) · Journal of Clinical Investigation · doi:10.1172/jci194740 · Cited by 40 · see citing works

Diabetic gastroparesis: Therapeutic options

Alam, U., Asghar, O., & Malik, R. A. (2010) · Diabetes Therapy · doi:10.1007/s13300-010-0010-8 · Cited by 26 · see citing works

Newer pharmacological interventions directed at gut hormones for obesity

Camilleri, M., & Acosta, A. J. (2023) · British Journal of Pharmacology · doi:10.1111/bph.16278 · Cited by 26 · see citing works

Association between gastrointestinal phenotypes and weight gain in younger adults: a prospective 4-year cohort study

Pajot, G. J., Camilleri, M., Calderón, G., Davis, J. A., Eckert, D. J., Burton, D. D., & Acosta, A. J. (2020) · International Journal of Obesity · doi:10.1038/s41366-020-0593-8 · Cited by 23 · see citing works

New physiological effects of the incretin hormones GLP-1 and GIP.

Asmar, M. (2011) · PubMed · Cited by 21 · see citing works

THERAPY OF ENDOCRINE DISEASE: Amylin and calcitonin – physiology and pharmacology

Mathiesen, D. S., Lund, A., Holst, J. J., Knop, F. K., Lutz, T. A., & Bagger, J. I. (2022) · European Journal of Endocrinology · doi:10.1530/eje-21-1261 · Cited by 21 · see citing works

In Silico Design of Optimal Ratio for Co-Administration of Pramlintide and Insulin in Type 1 Diabetes

Micheletto, F., Man, C. D., Kolterman, O., Chiquette, E., Herrmann, K., Schirra, J., Kovatchev, B., & Cobelli, C. (2013) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2013.0054 · Cited by 24 · see citing works

Gastroparesis

Bouras, E. P., Roque, M. I. V., & Aranda‐Michel, J. (2013) · Nutrition in Clinical Practice · doi:10.1177/0884533613491982 · Cited by 21 · see citing works

Clinical Studies

Young, A. J. (2005) · Advances in pharmacology · doi:10.1016/s1054-3589(05)52018-0 · Cited by 21 · see citing works

Pramlintide: Clinical Strategies for Success

Alrefai, H. A., Latif, K. A., Hieronymus, L. B., Weakley, C. R., & Moss, R. J. (2010) · Diabetes Spectrum · doi:10.2337/diaspect.23.2.124 · Cited by 16 · see citing works

Pharmacokinetics of an Oral Drug (Acetaminophen) Administered at Various Times Relative to Subcutaneous Injection of Pramlintide in Subjects With Type 2 Diabetes

Kellmeyer, T., Kesty, N. C., Wang, Y., Frías, J. P., & Fineman, M. S. (2007) · The Journal of Clinical Pharmacology · doi:10.1177/0091270007300949 · Cited by 16 · see citing works

Pathogenesis and management of diabetic gastroparesis: An updated clinically oriented review

Uppaluri, S., Jain, M. A., Ali, H., Shingala, J., Amin, D., Ajwani, T., Fatima, I., Patel, N., Kaka, N., Sethi, Y., et al. (2024) · Diabetes & Metabolic Syndrome: Clinical Research & Reviews · doi:10.1016/j.dsx.2024.102994 · Cited by 14 · see citing works

Weight-centric pharmacological management of type 2 diabetes mellitus – An essential component of cardiovascular disease prevention

Muzurović, E. M., Dragnić, S., Medenica, S., Smolović, B., Bulajić, P., & Mikhailidis, D. P. (2020) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2020.107619 · Cited by 15 · see citing works

Adjunctive Therapy with Pramlintide in Patients with Type 1 or Type 2 Diabetes Mellitus

Nogid, A., & Pham, D. Q. (2006) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.26.11.1626 · Cited by 14 · see citing works

Primer on Pramlintide, an Amylin Analog

Traina, A. N., & Kane, M. P. (2011) · The Science of Diabetes Self-Management and Care · doi:10.1177/0145721711403011 · Cited by 12 · see citing works

Pramlintide for Post-Bariatric Hypoglycemia

Sheehan, A., Goldfine, A., Bajwa, M., Wolfs, D., Kozuka, C., Piper, J., Fowler, K. M., & Patti, M. (2022) · Diabetes, obesity and metabolism · doi:10.1111/dom.14665 · Cited by 11 · see citing works

Amylin

Phillips, L. K., & Horowitz, M. (2006) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/01.med.0000216969.59375.39 · Cited by 12 · see citing works

Type 2 Diabetes Mellitus: An Evidence-Based Approach to Practical Management

Lingvay, I., Rhee, C., & Raskin, P. (2008) · Humana Press eBooks · doi:10.1007/978-1-60327-043-4_10 · Cited by 12 · see citing works

A contemporary biological pathway of islet amyloid polypeptide for the management of diabetic dementia

Sah, S. K., Samuel, V. P., Dahiya, S., Singh, Y., Gilhotra, R. M., Gupta, G., Mishra, A., Sharma, R. K., Kumar, G. S., Sreeharsha, N., et al. (2019) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2019.04.022 · Cited by 11 · see citing works

Amylin reduces plasma glucagon concentration in cats

Furrer, D., Kaufmann, K., Reusch, C. E., & Lutz, T. A. (2009) · The Veterinary Journal · doi:10.1016/j.tvjl.2009.02.011 · Cited by 11 · see citing works

Effects of Glutamine on Gastric Emptying of Low- and High-Nutrient Drinks in Healthy Young Subjects—Impact on Glycaemia

Du, Y., Piscitelli, D., Ahmad, S., Trahair, L. G., Greenfield, J. R., Samocha‐Bonet, D., Rayner, C. K., Horowitz, M., & Jones, K. L. (2018) · Nutrients · doi:10.3390/nu10060739 · Cited by 10 · see citing works

Gastroparesis: an evidence-based review for the bariatric and foregut surgeon

Bardaro, S. J., Guerron, A. D., Romanelli, J. R., Soriano, I. S., King, K., Gibbs, K. E., Petrick, A. T., Menzo, E. L., Rosenthal, R. J., Kennedy, C. M., et al. (2023) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2023.02.018 · Cited by 8 · see citing works

Effects of pramlintide on energy intake and food preference in rats given a choice diet

Kern, K. A., DiBrog, A. M., Przybysz, J. T., & Mietlicki‐Baase, E. G. (2021) · Physiology & Behavior · doi:10.1016/j.physbeh.2021.113541 · Cited by 7 · see citing works

Physiological models for artificial pancreas development

VISENTIN, R., Schiavon, M., Basu, R., Basu, A., Man, C. D., & Cobelli, C. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815655-1.00015-6 · Cited by 7 · see citing works

Impact of gastric emptying and small intestinal carbohydrate absorption on glycemia in health and diabetes: therapeutic implications

Jalleh, R. J., Wu, T., Umapathysivam, M. M., Young, R. L., Jones, K. L., Marathe, C. S., Rayner, C. K., Plummer, M. P., & Horowitz, M. (2026) · Physiological Reviews · doi:10.1152/physrev.00009.2025 · Cited by 6 · see citing works

Incretin impact on gastric function in obesity: physiology, and pharmacological, surgical and endoscopic treatments

Camilleri, M. (2024) · The Journal of Physiology · doi:10.1113/jp287535 · Cited by 6 · see citing works

Neuroprotective Mechanisms of Amylin Receptor Activation, Not Antagonism, in the APP/PS1 Mouse Model of Alzheimer’s Disease

Corrigan, R. R., Labrador, L., Grizzanti, J., Mey, M., Piontkivska, H., & Casadesús, G. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-221057 · Cited by 5 · see citing works

Non-Insulin Treatments for Diabetes

Angueira-Serrano, E. (2013) · American Journal of Therapeutics · doi:10.1097/mjt.0b013e318235f2cb · Cited by 3 · see citing works

Prokinetic agents for gastroparesis

Parkman, H. P. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818586-5.00024-7 · Cited by 4 · see citing works

Relation between serum amylin level and epilepsy

Benlier, N., Özer, G., & Orhan, N. (2020) · The Egyptian Journal of Neurology Psychiatry and Neurosurgery · doi:10.1186/s41983-020-00164-5 · Cited by 4 · see citing works

Chronic pramlintide decreases feeding via a reduction in meal size in male rats

Kern, K. A., DiBrog, A. M., Kaur, K., Przybysz, J. T., & Mietlicki‐Baase, E. G. (2024) · Peptides · doi:10.1016/j.peptides.2024.171197 · Cited by 3 · see citing works

Incretins and amylin in pediatric diabetes

Wood, J., & Silverstein, J. H. (2013) · Current Opinion in Pediatrics · doi:10.1097/mop.0b013e328362fdfb · Cited by 3 · see citing works

Use of continuous glucose monitoring to introduce adjunctive pramlintide therapy in a patient with type 1 diabetes: A case study

Walker, T. C. (2011) · Journal of the American Academy of Nurse Practitioners · doi:10.1111/j.1745-7599.2011.00652.x · Cited by 3 · see citing works

Medical Management of Obesity as it Affects Reflux

Haddad, J. D., & Shah, S. L. (2021) · Foregut The Journal of the American Foregut Society · doi:10.1177/26345161211069183 · Cited by 3 · see citing works

DIABETES MELLITUS

Rizza, R. A., & Vella, A. V. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-3291-5.50041-x · Cited by 3 · see citing works

A Review of Pramlintide in the Management of Diabetes

Messer, C., & Green, D. (2009) · Clinical Medicine Therapeutics · doi:10.4137/cmt.s2369 · Cited by 2 · see citing works

Diabetic gastroparesis: Therapeutic options

Alam, U., Asghar, O., & Malik, R. A. (2010) · Diabetes Therapy · doi:10.1007/s13300-010-002-82010 · Cited by 2 · see citing works

Study of Diabetic Gastroparesis

Bharucha, A. E. (2015) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2015.02.011 · Cited by 2 · see citing works

Person Centered Approach and Challenges in the Management of Obesity

Garcha, S. C., & Kalra, S. (2025) · Springer eBooks · doi:10.1007/978-981-96-1651-0_7 · Cited by 1 · see citing works

The I slet Amyloid Polypeptide hormone Amylin: Its function, effec ts and uses in medicine

Roberson, S. W. (2013) · Cited by 1 · see citing works

Medical Management of Gastroparesis: Diet and Medications

Jacob, D. A., & Camilleri, M. (2019) · Springer eBooks · doi:10.1007/978-3-319-96122-4_69 · Cited by 1 · see citing works

Prokinetic Agents for Gastroparesis

Parkman, H. P. (2011) · Humana Press eBooks · doi:10.1007/978-1-60761-552-1_22 · Cited by 1 · see citing works

Frequent Occurrence of Rapid as Well as Delayed Gastric Emptying of a Corn Flakes and Milk Meal in Clinical Patients With Gastrointestinal Symptoms

Santiago-Maldonado, I. M., & Phillips, W. T. (2007) · Clinical Nuclear Medicine · doi:10.1097/01.rlu.0000255028.99539.d3 · Cited by 1 · see citing works

The Physiology and Pharmacology of Diabetic Gastropathy Management

Dolan, R. D., Rohani, T. S., Muttineni, D., & Mashimo, H. L. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00045-1 · Cited by 1 · see citing works

Gastrointestinal Manifestations of Diabetes

Bharucha, A. E., & Camilleri, M. (2010) · doi:10.1002/9781444324808.ch46 · Cited by 1 · see citing works

Gastrointestinal and Autonomic Complications of Diabetes Mellitus

Vella, A. V., & Camilleri, M. (2007) · CRC Press eBooks · doi:10.3109/9780849379581-23 · Cited by 1 · see citing works

Pramlintide, an amylin analog, selectively delays gastric emptying: potential role of vagal inhibition

Samsom, M., Szarka, L. A., Camilleri, M., Vella, A. V., Zinsmeister, A. R., & Rizza, R. A. (2000) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.2000.278.6.g946 · Cited by 147 · see citing works

The effect of single doses of pramlintide on gastric emptying of two meals in men with IDDM

Kong, M.-F., Stubbs, T. A., King, P., Macdonald, I. A., Lambourne, J. E., Blackshaw, P. E., Perkins, A. C., & Tattersall, R. B. (1998) · Diabetologia · doi:10.1007/s001250050949 · Cited by 106 · see citing works

Infusion of pramlintide, a human amylin analogue, delays gastric emptying in men with IDDM

Kong, M.-F., King, P., Macdonald, I. A., Stubbs, T. A., Perkins, A. C., Blackshaw, P. E., Moyses, C., & Tattersall, R. B. (1997) · Diabetologia · doi:10.1007/s001250050646 · Cited by 131 · see citing works

Amylin and the Gastrointestinal Tract

Macdonald, I. A. (1997) · Diabetic Medicine · doi:10.1002/(sici)1096-9136(199706)14:2+ · Cited by 30 · see citing works

Vagal inhibition in the retardation of gastric emptying of solids by the amylin analog, pramlintide, in diabetes mellitus

Lee, J.-S., Vella, A. V., Camilleri, M., Szarka, L. A., Daniel, D. A., Burton, D. B., Zinsmeister, A. R., & Rizza, R. A. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)84636-3 · Cited by 3 · see citing works